, a definitive demonstration of its physiological function remains elusive. In this review, we discuss some of the proposed functions of PrP C , focusing on recently suggested roles in cell adhesion, regulation of ionic currents at the cell membrane and neuroprotection. We also discuss recent evidence supporting the idea that PrP C may function as a receptor for soluble oligomers of the amyloid b peptide and possibly other toxic protein aggregates. These data suggest surprising new connections between the physiological function of PrP C and its role in neurodegenerative diseases beyond those caused by prions.
Introduction
Prion diseases are a group of rare and invariably fatal neurodegenerative disorders of humans and animals, characterized by dementia, motor dysfunction and cerebral amyloidosis. These disorders include Creutzfeldt-Jakob disease and Kuru in humans, as well as bovine spongiform encephalopathy and scrapie in animals. Prion diseases can arise either sporadically, as a result of mutations in the gene encoding the prion protein, or by infection from exogenous sources. A great deal of evidence indicates that the key event underlying all forms of prion diseases is the conformational conversion of a normal cell surface glycoprotein, called the cellular prion protein (PrP C ) into an aggregated, b-sheet-rich isoform called the scrapie prion protein (PrP Sc ) (Box 1) [1] . The infectious spread of prions occurs via PrP Sc -templated conversion of an endogenous pool of PrP C molecules, a process that has analogs in selfpropagating proteins described in other species [2] .
Despite compelling evidence for this mechanism of prion propagation, current understanding of the primary causes of neurodegeneration in prion diseases is still limited. Several kinds of experiments suggest that PrP Sc , or other pathological PrP conformers, require physiologically active PrP C on the cell membrane to exert their toxicity [3] . Interestingly, recent evidence indicates that PrP C may also mediate the toxicity of amyloid beta (Ab) oligomers that are associated with Alzheimer's disease (AD) [4] , and possibly other b-rich protein aggregates [5] . Therefore, defining the physiological activity of PrP C is not only crucial for understanding the pathogenesis of prion diseases, but may also provide fundamental insights into the pathogenesis of other neurodegenerative disorders caused by misfolded protein assemblies. Here, we review recent findings that have provided fresh insights into the potential physiological activities of PrP C and how these might be subverted to produce pathological effects.
A dual role for PrP C in prion diseases It is widely agreed that PrP C plays a crucial role in the pathogenesis of prion diseases by virtue of its ability to serve as substrate for the generation of PrP Sc . However, several reports have underscored the distinction between prion infectivity and prion toxicity, and provided evidence that alterations in the normal function of PrP C may lie at the root of prion-induced neurodegenerative processes. In particular, recent experiments suggest that accumulation of infectivity and neurodegeneration proceed in distinct chronological and mechanistic phases. Infectivity accumulates relatively rapidly, and requires only a minimum expression level of PrP C , whereas neurodegeneration takes much longer and is directly dependent on the amount of PrP C expressed in the brain [6] . A dramatic demonstration of the dissociation of infectivity and pathology is the observation that genetically depleting neuronal PrP C in mice with established prion infection reverses neuronal loss and progression of clinical signs, despite the continuous production of infectious PrP Sc by surrounding astrocytes [7] . Similarly, the absence of endogenous PrP C renders host brain tissue resistant to the toxic effects of PrP Sc emanating from implanted graft tissue [8] . Finally, the absence of the glycolipid membrane anchor on PrP C has been shown to cause dramatic changes in the characteristics of scrapieinduced illness [9, 10] . Taken together, these lines of evidence indicate that the toxicity of PrP Sc requires the presence of membrane-anchored PrP C at the cell surface, and suggest that the normal, physiological activity of the protein is subverted to create toxicity.
Previous attempts to understand the function of PrP C Although PrP C was first identified as a normal cellular protein almost 20 years ago [11] , its physiological function has remained uncertain. The creation of mice carrying targeted disruption of the gene encoding PrP represents a possible approach to this problem. Since 1992, several lines of PrP-knockout mice have been engineered [12, 13] . These animals display resistance to prion infection, as predicted by the prion hypothesis, because they lack PrP C molecules to serve as substrates for the generation of PrP Sc [14] . With only one notable exception, however (owing to artefactual upregulation of an adjacent gene [15] ), PrP-knockout mice
